IFNA2 and COVID-19: This latter finding was markedly confirmed in a large cohort where auto-Abs neutralizing low concentrations of IFN-α and/or -ω (100 pg/mL, in 1/10 dilutions of plasma) were found in 13.6% of 3,595 patients with critical COVID-19 (19).